Gadolinium is a heavy metal toxin used in compact discs, computer memory, nuclear marine propulsion systems and dyes for magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA). In May 2007, the Food and Drug Administration warned of the risk of gadolinium side effects—particularly the risk of nephrogenic systemic fibrosis, or NSF, in kidney patients.
Patients sometimes receive an injection of a gadolinium-based dye prior to an MRI to enhance images of the body’s internal structures. In patients with normal kidney function, the dye is rapidly flushed through the kidneys. However, patients with kidney failure or kidney insufficiencies have difficulty flushing the gadolinium through their system, and consequently face a greater risk of developing NSF.
NSF is a rare systemic disease that affects the skin and muscles as well as the internal organs in some cases. The disease is initially characterized by a thickening and tightening of the skin that may eventually involve the muscles, diaphragm, lungs, and other internal structures. Symptoms of NSF include:
According to the FDA, deaths due to NSF complications have been reported. The agency also noted that the disease may take days to many months to become apparent after a person is exposed to a gadolinium-based contrast agent.
Gadolinium has been linked to a number of other side effects, including:
Individuals who have been exposed to a gadolinium-based contrast agent and experience any signs or symptoms of a gadolinium side effect should consult with a physician as soon as possible.
If you’ve been diagnosed with NSF and a gadolinium-based contrast agent is to blame, you may be entitled to compensation. Let us evaluate your case free of charge. We are happy to discuss your legal options with you.
To learn more about how we can help you with your case, please contact us.